304 related articles for article (PubMed ID: 7374415)
1. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
Schwartzkopff W; Schilling A; Calder D
Med Welt; 1980 Apr; 31(14):515-20. PubMed ID: 7374415
[No Abstract] [Full Text] [Related]
2. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
Kaffarnik H; Schneider J; Schubotz R; Zöfel P; Hausmann L; Goebel KM
Artery; 1980; 8(6):537-46. PubMed ID: 6114725
[TBL] [Abstract][Full Text] [Related]
3. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
4. The effect of etofibrate retard, bezafibrate and procetofen.
Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
Artery; 1980; 8(2):128-33. PubMed ID: 7458677
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of lipoproteinemia. Comparison between Lipo-Merz retard and a commercial combination drug].
Steger W
Fortschr Med; 1980 May; 98(18):(718-20). PubMed ID: 7390386
[TBL] [Abstract][Full Text] [Related]
6. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Dimroth H
Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
[TBL] [Abstract][Full Text] [Related]
7. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Artery; 1980; 8(2):113-9. PubMed ID: 7458676
[TBL] [Abstract][Full Text] [Related]
8. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
9. [Clofibrate therapy--the status quo].
Reuter W
Z Gesamte Inn Med; 1982 Jan; 37(2):59-63. PubMed ID: 7080553
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
11. Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis.
Sirtori M; Montanari G; Gianfranceschi G; Malacrida MG; Battistin P; Morazzoni G; Tremoli E; Colli S; Maderna P; Sirtori CR
Atherosclerosis; 1983 Nov; 49(2):149-61. PubMed ID: 6365105
[TBL] [Abstract][Full Text] [Related]
12. Plafibride treatment and serum lipids in hyperlipoproteinemias.
Rodriguez F; López IM; Jover E
J Med; 1987; 18(3-4):153-63. PubMed ID: 3323393
[TBL] [Abstract][Full Text] [Related]
13. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
Sommariva D; Scotti L; Baroni L; Beggi P; Fasoli A
Clin Ter; 1980 Mar; 92(6):649-55. PubMed ID: 7460493
[No Abstract] [Full Text] [Related]
14. Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate).
Uccella R; Morenghi R; Agosti C; Saponati G
Artery; 1983; 11(5):400-12. PubMed ID: 6661043
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia.
Packard CJ; Stewart JM; Third JL; Morgan HG; Lawrie TD; Shepherd J
Biochim Biophys Acta; 1980 Apr; 618(1):53-62. PubMed ID: 6990991
[No Abstract] [Full Text] [Related]
16. Treatment of hyperlipoproteinemia type II with etofibrate.
Gustafson A
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):498-502. PubMed ID: 528096
[TBL] [Abstract][Full Text] [Related]
17. [Atherosclerosis treatment with etofibrate retard. New perspectives].
Degenring FH; Schatton W; Hotz W
Fortschr Med; 1983 Aug; 101(30):1391-6. PubMed ID: 6618402
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate therapy of hyperlipoproteinaemia. A dose-response study and a comparison with clofibrate.
Rössner S; Orö L
Atherosclerosis; 1981; 38(3-4):273-82. PubMed ID: 7225166
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with bezafibrate.
Schubotz R; Schneider J; Hausmann L; Mühlfellner G; Mühlfellner O; Kaffarnik H
Artery; 1980; 8(6):553-9. PubMed ID: 7259534
[TBL] [Abstract][Full Text] [Related]
20. [Comparative research on etofibrate retard and fenofibrate in hyperlipoproteinemia].
Schwartzkopff W; Schilling A
Med Welt; 1980 Dec; 31(50):1845-50. PubMed ID: 7464535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
